Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.
作者信息
Balbi Manrico, Fedele Massimiliano, Bezante Gian P, Brunelli Claudio, Barsotti Antonio
出版信息
J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):839-42. doi: 10.2459/JCM.0b013e328337d7e7.
PMID:20216229
Abstract
摘要
相似文献
1
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy.
J Cardiovasc Med (Hagerstown). 2011 Nov;12(11):839-42. doi: 10.2459/JCM.0b013e328337d7e7.
2
Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.
Circ J. 2010 Nov;74(11):2314-21. doi: 10.1253/circj.cj-10-0347. Epub 2010 Oct 2.
3
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013.
4
A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
Cardiology. 2007;108(4):273-4. doi: 10.1159/000096989. Epub 2006 Nov 14.
5
The excel stent: a good DES, but can we really stop clopidogrel after 6 months?
JACC Cardiovasc Interv. 2009 Apr;2(4):310-1. doi: 10.1016/j.jcin.2009.01.005.
6
Symptomatic abnormal vessel wall reaction after implantation of the first generation sirolimus-eluting stent: a case series.
Cardiovasc Revasc Med. 2012 May-Jun;13(3):196-200. doi: 10.1016/j.carrev.2012.02.008.
7
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization.
Vasc Health Risk Manag. 2009;5(1):101-19. doi: 10.2147/vhrm.s4248. Epub 2009 Apr 8.
8
Very late stent thrombosis: simultaneous two-arterial occlusions.
Cardiovasc Revasc Med. 2008 Oct-Dec;9(4):281-3. doi: 10.1016/j.carrev.2007.08.007.
9
Simultaneous very late stent thrombosis in multiple coronary arteries.
Tex Heart Inst J. 2012;39(5):630-4.
10
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
JACC Cardiovasc Interv. 2011 Jan;4(1):66-75. doi: 10.1016/j.jcin.2010.09.017.
Zotero 插件